cdx 6114
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2019 (NCT04085666)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Phenylalanine ammonia-lyaseSupplementation
Phenylalanine ammonia-lyase supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04256655 | Phase 1 | Apr 1, 2020 | Nestle |
| NCT04085666 | Phase 1 | Jun 1, 2019 | Linear Clinical Research, Nestle, Profil GmbH |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nestle | For profit | 2 | 2 | 1 | 2019 |
| Linear Clinical Research | For profit | 1 | 0 | 1 | 2019 |
| Profil GmbH | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1